Markt oder Branche auswählen:
Chart-Typ:
Zeitraum:
| Research and Markets: Europe Sodium-Ion Battery Analysis Report 2025: Market to Reach $1.49 Billion by 2035 from $50 Million in 2024, Driven by Sustainability, Energy Security, and Reduced Reliance on Imports - ResearchAndMarkets.com | The "Europe Sodium-Ion Battery Market: Focus on Application, Product, and Country Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.
The Europe sodium-ion... ► Artikel lesen |
| Dividendenbekanntmachungen (13.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABN AMRO BANK NV NL0011540547 - 0,54 EUR ADCORP HOLDINGS LIMITED ZAE000000139 0,5001 ZAR 0,0243 EUR AERCAP HOLDINGS NV NL0000687663 0... ► Artikel lesen |
| Reliance Industries to start solar cell production in India in Q3 | Reliance Industries Ltd. (RIL) is set to commission its solar cell factory in the third quarter, achieving a significant milestone in its goal of building a fully integrated solar manufacturing value... ► Artikel lesen |
| Dividendenbekanntmachungen (21.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,065 EUR ALLISON TRANSMISSION HOLDINGS INC US01973R1014 0,27 USD 0,2341 EUR ALPHAMIN... ► Artikel lesen |
| ST Engineering iDirect and Black Cat Systems Unveil Advanced Satcom Lab to Support Australian Defence Force | Highlighting the 450SDM multi-waveform, multi-orbit modem built for mission-critical communications
HERNDON, Va., Nov. 17, 2025 /PRNewswire/ -- ST Engineering iDirect... ► Artikel lesen |
| ST Engineering iDirect Powers Verizon Frontline's Infrastructure Upgrade for Emergency Communications | HERNDON, Va., Nov. 3, 2025 /PRNewswire/ -- ST Engineering iDirect, a leader in satellite communications, today announced its continued partnership with Verizon Frontline to enhance... ► Artikel lesen |
| Takeda Shares Promising Interim Results For Mezagitamab In IgA Nephropathy | TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK) announced new interim findings from its Phase 1b open-label proof-of-concept trial evaluating subcutaneous mezagitamab (TAK-079)... ► Artikel lesen |
| Takeda Reports Positive Long-Term Data From Phase 3 Trial Of Dengue Vaccine QDENGA | TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK) on Monday reported positive seven-year results from its pivotal Phase 3 TIDES trial evaluating the company's dengue vaccine, QDENGA... ► Artikel lesen |
| Takeda Pharma H1 Net Profit Declines; Revenue Down 6.9% | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK) reported first half net profit to owners of company of 112.4 billion yen, down 40.0% from prior year. Earnings... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .